ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.

Area of Science:

• Biopharmaceutical Manufacturing
• Analytical Chemistry
• Proteomics

Background:

• Host cell proteins (HCPs) are critical impurities in recombinant therapeutics that necessitate rigorous removal during downstream processing.
• Enzyme-linked immunosorbent assay (ELISA) is the standard method for monitoring HCP clearance, but its coverage against all process-specific HCPs can be uncertain.
• Mass spectrometry (MS) offers detailed identification of HCP impurities but faces challenges in direct correlation with ELISA performance.

Purpose of the Study:

• To develop an efficient method for determining the coverage of ELISA reagents against specific host cell protein impurities.
• To integrate proteomic analysis with affinity purification for comprehensive HCP impurity characterization.
• To establish a framework for assessing ELISA reagent suitability and ensuring robust HCP clearance in biotherapeutic manufacturing.

Main Methods:

• Proteomic analysis using affinity purification with a polyclonal anti-HCP reagent (AP-MS) was employed to identify HCPs.
• HCP identifications from AP-MS were compared with actual downstream process impurities in a therapeutic monoclonal antibody.
• Coverage evaluation was performed using an anti-HCP polyclonal reagent against both HCP immunogens and process-specific impurities.

Main Results:

• AP-MS provides an efficient means to determine ELISA reagent coverage against HCP impurities.
• The method allows for a focused assessment of ELISA suitability by comparing identified HCPs with actual process impurities.
• Demonstrated utility in evaluating anti-HCP polyclonal coverage for a therapeutic monoclonal antibody post-Protein A purification.

Conclusions:

• Affinity-based mass spectrometry (AP-MS) is a valuable tool for evaluating HCP process clearance and ELISA reagent coverage.
• This approach enhances the holistic assessment of HCP impurity risks in biopharmaceutical development.
• AP-MS complements existing analytical methods by focusing on product-specific HCP impurities, improving overall process understanding and control.